JORDAN ERICA (Chief Commercial Officer) sold 2.0% of their position (2.39K shares) of REVANCE THERAPEUTICS, INC. on the open market
Open‑market sale worth $9.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/17/2024ACC: 0001479290-24-000074
Officer· Chief Commercial Officer
Since Feb 2024
-2.39K
Net shares
Net seller
$9.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.39K
Price / share
$3.80
Trade value
$9.10K
% of position
2.0%
4/16/2024
117.26K→114.86K
Total
Net shares
−2.39K
Net value
-$9.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2024 | S · Sale | −2.39K | $3.80 | $9.10K | 2.0% | 117.26K | 114.86K |
| Total | −2.39K | -$9.10K | ||||||
Derivative Transactions0
No derivative transactions reported